WASHINGTON — Congress reconvenes this week with a packed health care agenda that could shape affordability and access for millions of Americans. Top priorities include finalizing Medicare drug price negotiations, addressing pandemic-era Medicaid coverage cliffs, and advancing bipartisan mental health reforms, according to legislative aides and policy analysts.
The returning session marks a critical window for the Biden administration’s health care objectives before election-year politics dominate the calendar. At stake are long-delayed measures to implement the Inflation Reduction Act’s drug pricing provisions, which face legal challenges from pharmaceutical companies. Analysts note the 2026 reconciliation process may offer a narrow pathway for adjustments.
‘This is the last realistic shot for substantive health legislation before midterms,’ said a Democratic staffer familiar with negotiations, speaking anonymously due to sensitivity. ‘Everything gets harder after August.’
Republican leaders have signaled opposition to expanding Medicare negotiation authority but express openness to targeted reforms. ‘We need market-based solutions, not price controls that stifle innovation,’ House Ways and Means Chair Jason Smith (R-MO) told reporters last week.
With 12 must-pass appropriations bills pending and a September 30 shutdown deadline, observers warn health provisions could get sidelined. However, the looming expiration of COVID-era Medicaid continuous enrollment policies — projected to displace 15 million beneficiaries — creates urgent pressure for action.